Above posted on the company web-site:

https://www.zenithepigenetics.com/newsroom/corporate-information

Just a quick glance through the document:

- Actual reason why the TNBC trial is discontinued (which we heard accidentally in the other company AGM) in the US/EU.  Page 4.

- mCRPC trial still moving along, esp cohort B (AR independent).

- How much the warrants & RSUs have ballooned (not surprise) as of Aug 29, 2023. Page 11

- "We recorded a corresponding $1.4 million expense due to an isolated email compromise which resulted in the misdirection of the proceeds from the private placement....."  on page 6. ????????